Valuation: BIONET Corp.

Market Cap 2.99B 92.53M 81.27M 75.58M 69.35M 130M 8.91B 132M 897M 351M 4.38B 347M 340M 15.15B P/E 2024
48.2x
P/E 2025 102x
Enterprise Value 1.71B 52.82M 46.39M 43.14M 39.59M 74.38M 5.09B 75.53M 512M 200M 2.5B 198M 194M 8.65B EV / Sales 2024
2.09x
EV / Sales 2025 3.17x
Free-Float
77.12%
Yield 2024
1.78%
Yield 2025 0.84%
1 day-1.82%
1 week-2.14%
Current month-12.11%
1 month-12.50%
3 months-21.19%
6 months-40.50%
Current year-42.51%
1 week 59.2
Extreme 59.2
62.3
1 month 59.2
Extreme 59.2
73.8
Current year 59.2
Extreme 59.2
118
1 year 59.2
Extreme 59.2
118
3 years 51.92
Extreme 51.9178
162.01
5 years 32.78
Extreme 32.7754
162.01
10 years 20.08
Extreme 20.0761
162.01
Manager TitleAgeSince
Chief Executive Officer - 01/09/2006
Director of Finance/CFO - 23/03/2018
Director TitleAgeSince
Chairman - 01/08/2000
Director/Board Member - 11/04/2003
Director/Board Member 77 21/11/2006
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-2.14%-20.03%-3.75% 92.53M
+1.07%-3.49%-3.35%+10.44% 46.86B
+0.25%+1.65%+399.22%+634.87% 40.23B
-0.27%+4.45%+11.81%+65.64% 36.23B
+0.35%+0.87%+4.46%-10.16% 34.72B
+3.14%+1.02%+4.76%+40.92% 27.89B
-0.73%+11.84%+34.39%+134.36% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%-3.43%+9.03% 13.12B
-2.68%-2.49%-11.36%-33.61% 12.7B
Average +0.02%+0.61%+46.27%+94.20% 24.54B
Weighted average by Cap. +0.48%+0.91%+74.38%+136.22%

Financials

2024 2025
Net sales 1.22B 37.78M 33.18M 30.85M 28.31M 53.2M 3.64B 54.02M 366M 143M 1.79B 142M 139M 6.18B 1.24B 38.23M 33.57M 31.22M 28.65M 53.83M 3.68B 54.66M 371M 145M 1.81B 143M 140M 6.26B
Net income 83.7M 2.59M 2.27M 2.11M 1.94M 3.64M 249M 3.7M 25.1M 9.8M 122M 9.71M 9.5M 424M 51.43M 1.59M 1.4M 1.3M 1.19M 2.24M 153M 2.27M 15.42M 6.02M 75.26M 5.97M 5.84M 260M
Net Debt -1.48B -45.76M -40.19M -37.37M -34.3M -64.44M -4.41B -65.43M -444M -173M -2.17B -172M -168M -7.49B -1.28B -39.71M -34.88M -32.44M -29.76M -55.92M -3.82B -56.79M -385M -150M -1.88B -149M -146M -6.5B
Logo BIONET Corp.
BIONET CORP. is a Taiwan-based company principally engaged in the storage and application of hematopoietic stem cells. The Company’s main products include umbilical cord blood stem cells, mesenchymal stem cells, adult peripheral blood stem cells and others. The Company also provides precision medical application, prenatal testing and genetic testing services. The Company operates its businesses mainly in domestic market.
Employees
-
Date Price Change Volume
24/07/26 NT$59.50 -1.82% 135,908
23/07/26 NT$60.60 -0.33% 86,551
22/07/26 NT$60.80 +1.00% 100,796
21/07/26 NT$60.20 -0.17% 105,200
20/07/26 NT$60.30 -0.82% 389,699
  1. Stock Market
  2. Stocks
  3. 1784 Stock